Caspases in apoptotic death

Bibliography

• KERR JF, WYLLIE AH, CURRIE AR: Apoptosis:abasicbio-logical phenomenon with wide-ranging implications intissuekinetics.Br. J. Cancer(1972) 26:239–257.
   PubMed Web of Science ®Google Scholar
• WYLLIE AH: Glucocorticoid-inducedthymocyteapop-tosis is associated with endogenous endonuclease acti-vation.Nature(1980) 284:555–556.
   PubMed Web of Science ®Google Scholar
• NICHOLSON DW, THORNBERRY NA: Caspases:killerproteases.Trends Biochem. ScL(1997) 22:299–306.
   PubMed Web of Science ®Google Scholar
• COHEN GM: Caspases:theexecutionersofapoptosis.Biochem. J.(1997) 326:1–16.
   PubMed Web of Science ®Google Scholar
• WYLLIE AH: Apoptosisandcarcinogenesis.EMBO J.(1998) 17:37–49.
   Google Scholar
• BOUDREAU N, SYMPSON CJ, WERB Z et al.:Suppressionof ICE and apoptosis in mammary epithelial cells by extracellularmatrix.Science(1995) 267:891–893.
   PubMed Web of Science ®Google Scholar
• GREEN DR, MARTIN SJ: Thekillerandtheexecutioner:howapoptosiscontrolsmalignancy.Curr. Opin. Immu-nol.(1995) 7:694–703.
   PubMed Web of Science ®Google Scholar
• ANKARCRONA M, DYPBUKT JM, BONFOCO E et al:Glutamate-induced neuronal death: a succession of ne-crosis or apoptosis depending on mitochondrial func-tion.Neuron(1995) 15:961–973.
   PubMed Web of Science ®Google Scholar
• HIRSCH T, MARCHETTI P, SUSIN SA et al:Theapoptosis-necrosis paradox. Apoptogenic proteases activated af-ter mitochondrial permeability transition determine themodeofcelldeath.Oncogene(1997) 15:1573–1581.
   Google Scholar
• SHIMIZU S, EGUCHI Y, KAMIIKE W et al.:Retardationofchemical hypoxia-induced necrotic cell death by Bc1-2 and ICE inhibitors: possible involvement of common mediators in apoptotic and necrotic signal transduc-tion.Oncogene(1996) 12:2045–2050.
   PubMed Web of Science ®Google Scholar
• MILLER DK: Theroleofthecaspasefamilyofcysteineproteasesinapoptosis.Semin. Immunol.(1997) 9:35–49.
   PubMed Web of Science ®Google Scholar
• SALVESEN GS, DIXIT VM: Caspases:intracellularsignal-ingbyproteolysis.Cell(1997) 91:443–446.
   PubMed Web of Science ®Google Scholar
• VILLA P, KAUFMANN SH, EARNSHAW WC: Caspasesandcaspaseinhibitors.Trends Biochem. ScL(1997) 22:388–393.
   PubMed Web of Science ®Google Scholar
• THRONBERRY NA, ROSEN A, NICHOLSON DW: Controlofapoptosisbyproteases.Adv. Pharmacol.(1997) 41:155–177.
   PubMedGoogle Scholar
• ALNEMRI ES, LIVINGSTON DJ, NICHOLSON DW eta].:Hu-manICE/CED-3proteasenomenclature.Cell(1996) 87:171.
   Google Scholar
• MUZIO M, STOCKWELL BR, STENNICKE HR et al.:Anin-ducedproximitymodelforcaspase-8activation.J. Biol. Chem.(1998) 273:2926–2930.
   Google Scholar
• MACCORKLE RA, FREEMAN KW, SPENCER DM: Syntheticactivationofcaspases:artificialdeathswitches.Proc. Natl. Acad. ScL USA(1998) 95:3655–3660.
   PubMed Web of Science ®Google Scholar
• ZHOU Q, SALVESEN GS: Activationofpro-caspase-7byserine proteases includes a non-canonical specificity. Biochem J.(1997) 324:361–364.
   PubMed Web of Science ®Google Scholar
• YUAN J: Transducingsignalsoflifeanddeath.Curr. Opin. Cell. Biol.(1997) 9:247–251.
   PubMed Web of Science ®Google Scholar
• HAN Z, HENDRICKSON EA, BREMNER TA et al.:Asequen-tial two-step mechanism for the production of the ma-turep17:p12formofcaspase-3invitro.J. Biol. Chem.(1997) 272:13432–13436.
   Google Scholar
• YANG X, CHANG HY, BALTIMORE D: Autoproteolyticac-tivationofpro-caspasesbyoligomerization.Mol.(1998) 1:319–325.
   Google Scholar
• MITTL PRE, DIMARCO S, KREBS JF et al.:Structureofre-combinant human cpp32 in complex with the tet-r ape ptide acetyl-Asp-Val-Ala-Asp fluoromethyl ketone.J. Biol. Chem.(1997) 272:6539–6547.
   Google Scholar
• TALANIAN RV, QUINLAN C, TRAUTZ S et al.:Substratespecificitiesofcaspasefamilyproteases.J. Biol. Chem.(1997) 272:9677–9682.
   PubMed Web of Science ®Google Scholar
• RANO TA, TIMKEY T, PETERSON EP et al.:Acombinato-rial approach for determining protease specificities: application to interleukin-lbeta converting enzyme (ICE).Chem. Biol.(1997) 4:149–155.
   PubMed Web of Science ®Google Scholar
• THORNBERRY NA, RANO TA, PETERSON EP et al:Acom-binatorial approach defines specificities of members ofthecaspasefamilyandgranzymeB.J. Biol. Chem.(1997) 272:17907–17911.
   PubMed Web of Science ®Google Scholar
• MARGOLIN N, RAYBUCK SA, WILSON KP et al:Substrateand inhibitor specificity of interleukin-6-converting enzymeandrelatedcaspases.J. Biol. Chem.(1997) 272:7223–7228.
   PubMed Web of Science ®Google Scholar
• FALEIRO L, KOBAYASHI R, FEARNHEAD H et al.:Multiplespecies of CPP32 and Mch2 are the major active cas-pasespresentinapoptoticcells.EMBO J.(1997) 16:2271–2281.
   PubMed Web of Science ®Google Scholar
• WANG Z-Q, AUER B, STINGL L et al.:MicelackingADPRTand poly(ADP-ribosyl) ation develop normally but are susceptibletoskindisease.Genes Dev.(1995) 9:509–520.
   PubMed Web of Science ®Google Scholar
• FERNANDES-ALNEMRI T, ARMSTRONG R, KREBS J et al:In vitro activation of cpp32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-likedomains.Proc. Natl. Acad. ScL USA(1996) 93:7464–7469.
   PubMed Web of Science ®Google Scholar
• HIRATA H, TAKAHASHI A, KOBAYASHI S et al:Caspasesare activated in a branched protease cascade and con-trol distinct downstream processes in Fas-induced apoptosis.J. Exp. Med.(1998) 187:587–600.
   PubMed Web of Science ®Google Scholar
• SCHWARTZ SM: Celldeathandthecaspasecascade.Cir-culation(1998) 97:227–229.
   PubMed Web of Science ®Google Scholar
• MARTIN SJ, FINUCANE DM, AMARANTE-MENDES et al.:Phosphatidylserine externalization during CD95-induced apoptosis of cells and cytoplasts requires ICE/CED-3proteaseactivity.J. Biol. Chem.(1996) 271:28753–28756.
   Google Scholar
• VANAGS DM, PORN-ARES M, COPPOLA S et al.:Proteaseinvolvement in fodrin cleavage and phosphatidlyser-ineexposureinapoptosis.J. Biol. Chem.(1996) 271:31075–31085.
   PubMed Web of Science ®Google Scholar
• BORTNER CD, HUGHES FM, CIDLOWSKI JA: Aprimaryrole for K+ and Na+ efflux in the activation of apopto-sis.J. Biol. Chem.(1997) 272:32436–32442.
   PubMed Web of Science ®Google Scholar
• XU DG, CROCKER SJ, DOUCET JP et al:Elevationofneu-ronal expression of NALP reduces ischemic damage in therathippocampus.Nature Med.(1997) 3:997–1004.
   PubMed Web of Science ®Google Scholar
• OKURA T, GONG LM, KAMITANI T et al.:Protectionagainst Fas/APO-1- and tumor necrosis factor-mediatedcelldeathbyanovelprotein,sentrin.J. Im-munol(1996) 157:4277–4281.
   Google Scholar
• AMBROSINI G, ADIDA C, ALTIERI DC: Anovelanti-apoptosis gene, survivin, expressed in cancer and lymphoma.Nature Med.(1997) 3:917–921.
   PubMed Web of Science ®Google Scholar
• MANCINI M, NICHOLSON DW, ROY S et al:Thecaspase-3precursor has a cytosolic and mitochondrial distribu-tion:implicationsforapoptoticsignaling.J. Cell. Biol.(1998) 140:1485–1495.
   PubMed Web of Science ®Google Scholar
• HERMANN C, ZEIHER AM, DIMMELER S: Shearstressin-hibits 11202-induced apoptosis of human endothelial cellsby modulation of the glutathione redox cycle and nitricoxidesynthase.Arterioscler. Thromb. Vasc. Biol.(1997) 17:3588–3592.
   PubMed Web of Science ®Google Scholar
• NOVEL CSI, KIMLAND M, NICHJOLSON DW et al.:Disulfi-ram is a potent inhibitor of proteases of the caspase family.Chem. Res. Toxicol(1997) 10:1319–1324.
   PubMed Web of Science ®Google Scholar
• KIM Y-M, TALANIAN RV, BILLIAR TR: Nitricoxideinhib-its apoptosis by preventing increases in caspase-3-like activityviatwodistinctmechanisms.J. Biol. Chem.(1997) 272:31138–31148.
   PubMed Web of Science ®Google Scholar
• HAENDELER J, WEILAND U, ZEIHER AM et al.:Effectsofredox-related congeners of NO on apoptosis and caspase-3activity.Nitric Oxide Biol. Chem.(1997) 1:282–293.
   Google Scholar
• BOSSY-WETZEL E, NEWMEYER DD, GREEN DR: Mito-chondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and in-dependently of mitochondrial transmembrane depo-larization.EMBO J(1998) 17:37–49.
   PubMed Web of Science ®Google Scholar
• ZOU H, HENZEL WJ, LIU X et al:Apaf-1ahumanproteinhomologous to C. elegans ced-4, participates in cyto-chromec-dependentactivationofcaspase-3.Cell(1997) 90:405–413.
   Google Scholar
• LIU X, ZOU H, SLAUGHTER C et al.:DFF,aheterodimericprotein that functions downstream of caspase-3 to triggerDNAfragmentationduringapoptosis.Cell(1997) 89:175–184.
   PubMed Web of Science ®Google Scholar
• HAMPTON MB, ZHIVOTOVSKY B, SLATER AFG et al:Im-portance of the redox state of cytochrome c during caspaseactivationincytosolicextracts.Biochem(1998) 329:95–99.
   Google Scholar
• ROSENTHAL DS, DING R, SIMBULAN-ROSENTHAL CM etal.:Intactcellevidencefortheearlysynthesis,andsub-sequent late apopain-mediated suppression, of poly (ADP-ribose)duringapoptosis.Exp. Cell. Res.(1997) 232:313–321.
   Google Scholar
• WYLLIE AH: Apoptosisandcarcinogenesis.Eur. J. Cell. Biol.(1997) 73:189–197.
   Google Scholar
• YUAN J, SHAHAM S, LEDOUX S et al.:TheC.eleganscelldeath gene ced-3 encodes a protein similar to mam-malianinterleukin-1beta-convertingenzyme.Cell(1993) 75:641–652.
   Google Scholar
• ZOU H, HENZEL WJ, LIU X et al:Apaf-1,ahumanproteinhomologous to C. elegans CED-4, participates in cyto-chromec-dependentactivationofcaspase-3.Cell(1997) 90:405–413.
   Google Scholar
• JACOBSON MD: Programmedcelldeath:amissinglinkisfound.Trends Cell. Biol.(1997) 7:467–469.
   PubMed Web of Science ®Google Scholar
• KOMIYAMA T, RAY CA, PICKUP AJ et al.:Inhibitionofinterleukin-16 converting enzyme by the cowpox vi-russerpinCrmA.J. Biol. Chem.(1994) 269:19331–19337.
   Google Scholar
• BUMP NJ, HACKETT M, HUGUNIN M et al:InhibitionofICE family proteases by baculovirus antiapoptotic pro-teinp35.Science(1995) 269: 1885-1888.
   Google Scholar
• SONG Z, MCCALL K, STELLER H: DCP-1,aDrosophilacelldeathproteaseessentialfordevelopment.Science(1997) 275:536–540.
   PubMed Web of Science ®Google Scholar
• FRASER A, EVAN G: IdentificationofaDrosophilamela-nogasterICE/CED-3-relatedprotease,drICE.EMBO J.(1997) 16:2805–2813.
   PubMed Web of Science ®Google Scholar
• WEIL M, JACOBSON MD, RAFF MC: Isprogrammedcelldeathrequiredforneuraltubeclosure?Curr.(1997) 7:281–284.
   Google Scholar
• WALKER NPC, TALANIAN RV, BRADY KD et al.:Crystalstructure of the cysteine protease interleukin-lbeta-convertingenzyme:A(p20/p10)2homodimer.Cell(1994) 78:343–352.
   PubMed Web of Science ®Google Scholar
• WILSON KP, BLACK JAF, THOMSON JA et al.:Structureand mechanism of interleukin-19 converting enzyme. Nature(1994) 370:270–274.
   PubMed Web of Science ®Google Scholar
• ROTONDA J, NICHOLSON DW, FAZIL KM et al.:Thethree-dimensional structure of apopain/cpp32, a key mediatorofapoptosis.Nature Struct. Biol.(1996) 3:619–625.
   Google Scholar
• CHAPMAN KT: Synthesisofapotent,reversibleinhibi-torofinteleukin-113convertingenzyme.Bioorg. Med. Chem. Lett.(1992) 2:613–618.
   Web of Science ®Google Scholar
• THRONBERRY NA, BULL HG, CALAYCAY JF et al.:Anovelheterodimeric cysteine protease is required for interleukin-1betaprocessinginmonocytes.Nature(1992) 356:768–774.
   PubMed Web of Science ®Google Scholar
• THORNBERRY NA, MOLINEAUX SM: Interleukin-19con-verting enzyme: a novel cysteine protease required for IL-113 production and implicated in programmed cell death.Prot. Sci.(1995) 4:3–12.
   PubMed Web of Science ®Google Scholar
• THORNBERRY NA: Interleukin-19convertingenzyme.Meth. Enz.(1994) 244:615–631.
   PubMed Web of Science ®Google Scholar
• NICHOLSON DW, ALI A, THORNBERRY NA et al:Identifi-cation and inhibition of the ICE/CED-3 protease neces-saryformammalianapoptosis.Nature(1995) 376:37–43.
   PubMed Web of Science ®Google Scholar
• DOLLE RE, PRASAD CVC, PROUTY CP et al.:Pyridazinodi-azepines as a high-affinity P2-P3 peptidomimetic class ofinterleukin-19-convertingenzymeinhibitor.J. Med. Chem.(1997) 40:1941–1946.
   Google Scholar
• UHL J, KRASNEY P, BROPHY L et al.:Secretionofhumanmonocyte mature IL-19: optimization of culture condi-tionsandinhibitionbyICEinhibitors.Inflamm. Res.(1995) 44:s211–216.
   Google Scholar
• MILLER BE, KRASNEY PA, GAUVIN DM et al:Inhibitionofmature 11-113 production in murine macrophages and a murine model of inflammation by WIN 67694, an in-hibitorof11-113convertingenzyme.J. Immunol.(1995) 154:1331–1338.
   PubMed Web of Science ®Google Scholar
• ELFORD PR, HENG R, REVESZ L et al.:Reductionofin-flammation and pyrexia in the rat by oral administra-tion of SDZ 224–015, an inhibitor of the interleukin-113 convertingenzyme.Br. J. Pharmacol.(1995) 115:601–606.
   Google Scholar
• LI P, ALLEN H, BANERJEE S et alMicedeficientin 11-113-converting enzyme are defective in production ofmature11-113andresistanttoendotoxicshock.Cell(1995) 80:401–411.
   PubMed Web of Science ®Google Scholar
• KUIDA K, LIPPKE JA, KU G et al.:Alteredcytokineexportand apoptosis in mice deficient in interleukin-1 beta convertingenzyme.Science(1995) 267: 2000-2003.
   Google Scholar
• BERGERON L, PEREZ GI, MACDONALD G, etal:Defectsin regulation of apoptosis in caspase-2-deficient mice. Genes Dev.(1998) 12:1304–1314.
   PubMed Web of Science ®Google Scholar
• KUIDA K, ZHENG TS, NA S et al.:Decreasedapoptosisinthe brain and premature lethality in CPP32-deficient mice.Nature(1996) 384:368–372.
   PubMed Web of Science ®Google Scholar
• LODDICK SA, MACKENZIE A, ROTHWELL NJ: AnICEin-hibitor, z-VAD-DCB attenuates ischaemic brain dam-ageintherat.Neuroreport(1996) 7:1465–1468.
   PubMed Web of Science ®Google Scholar
• ENDRES M, NAMURA S, SHIMIZU-SASAMATA M et al.:At-tenuation of delayed neuronal death after mild focal ischemiainmicebyinhibitionofthecaspasefamily.J. Cereb. Blood. Flow Metab.(1998) 18:238–247.
   PubMed Web of Science ®Google Scholar
• ENDRES M, WANG ZQ, NAMURA S et al.:IschemicbraininjuryismediatedbytheactivationofPARP.J. Cereb. Blood Flow Metab.(1997) 17:1143–1151.
   PubMed Web of Science ®Google Scholar
• YAOITA H, OGAWA K, MAEHARE K et al:Attenuationofischemia/reperfusion injury in rats by a caspase in-hibitor.Circulation(1998) 97:276–281.
   PubMed Web of Science ®Google Scholar
• BLACKS, HUANG J, REZAIEFAR P et al.:Co-localizationofthe cysteine protease caspase-3 with apoptotic myo-cytes after in vivo myocardial ischemia and reperfu-sionintherat.J. Mol. Cell. Cardiol(1998) 30:733–742.
   Google Scholar
• KAUSHAL G, SINGH A, SHAH S: Identificationofgenefamily of caspases in rat kidney and altered expres-sioninischemia-reperfusioninjury.Am. J. Physiol(1998) 274:F587–95.
   PubMedGoogle Scholar
• SCHWARTZ LM, MILLIGAN CE: Coldthoughtsofdeath:theroleofICEproteasesinneuronalcelldeath.Trends Neurosci.(1996) 19:555–562.
   PubMed Web of Science ®Google Scholar
• FRASERA, MCCARTHY N, EVAN GI: Biochemistryofcelldeath.Curr. Opin. Neurobiol.(1996) 6:71–80.
   PubMed Web of Science ®Google Scholar
• MARTINOUJ-C, SADOUL R: ICE-likeproteasesexecutetheneuronaldeathprogram.Curr. Opin. Neurobiol(1996) 6:609–614.
   PubMed Web of Science ®Google Scholar
• LODDICK SA, MACKENZIE A, ROTHWELL NJ: AnICEin- hibitor, z-VAD-DCB attentuates ischaemic brain dam-ageintherat.Neuroreport(1996) 7:1465–1468.
   PubMed Web of Science ®Google Scholar
• ENDRES M, NAMURA S, SHIMIZU-SASAMATA M et al.:At- tenuationof delayed neuronal death after mild focal ischemiainmicebyinhibitionofthecaspasefamily.J. Cereb. Blood Flow Metab.(1998) 18:238–247.
   PubMed Web of Science ®Google Scholar
• BROMME HJ, HOLTZ J: Apoptosisintheheart:when andwhy?Mol. Cell. Biochem.(1996) 163/164:261-275. © Ashley Publications Ltd. All rights reserved.Exp. Opin. Invest. Drugs(1999) 8(1)
   Google Scholar
• GENG Y-J: Regulationofprogrammedcelldeathorapoptosisinatherosclerosis.Heart Vessels(1997) 12:76–80.
   Google Scholar
• MARCELLI M, CUNNINGHAM GR, HAIDACHER SJ et al.:Caspase-7 is activated during lovastatin-induced apop-tosisoftheprostatecancercelllineLNCaP.Cancer Res.(1998) 58:76–83.
   PubMed Web of Science ®Google Scholar